The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
FLT3 mutations in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML).
Pavan Kumar Bhamidipati
No relevant relationships to disclose
Naval Guastad Daver
No relevant relationships to disclose
Hagop Kantarjian
No relevant relationships to disclose
Sherry Pierce
No relevant relationships to disclose
Roshni Daver
No relevant relationships to disclose
Jorge E. Cortes
No relevant relationships to disclose
Farhad Ravandi
No relevant relationships to disclose
Michael Mathisen
No relevant relationships to disclose
Naveen Pemmaraju
No relevant relationships to disclose
Aziz Nazha
No relevant relationships to disclose
Tapan M. Kadia
No relevant relationships to disclose
Elias Jabbour
No relevant relationships to disclose
Gautam Borthakur
No relevant relationships to disclose
Stefan Faderl
No relevant relationships to disclose
Guillermo Garcia-Manero
No relevant relationships to disclose